年龄和CYP2C19基因型对中国患者沃里康纳稳定状态最低度的相互作用
Yin-Xiao Du1,2,3, Ying-Xia Zhu1,2,3, Liang Li1,2,3
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University.
年龄和CYP2C19遗传变异显著影响伏利可纳水平. 较年轻的患者中,CYP2C19低代谢器基因型的影响更为明显,而年龄在老年人中是一个关键因素.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 沃里科纳是一种关键的抗真菌药物,其血度受患者年龄和CYP2C19酶的遗传变异的影响.
- 这些因素之间的相互作用,特别是在不同的年龄段,仍然不完全理解.
- 了解这些相互作用对于优化伏利康纳治疗和改善患者治疗结果至关重要.
研究的目的:
- 调查年龄和CYP2C19基因型对中国患者沃里康纳血度的综合影响.
- 确定年龄如何改变CYP2C19遗传多态性对利康纳暴露的影响.
主要方法:
- 分析了接受伏利康纳治疗的480名患者队列.
- CYP2C19*2和CYP2C19*3的多态性被基因型化.
- 患者被分为年轻人 (<60岁) 和老年人 (≥60岁) 群体,以评估依赖于年龄的波里科纳对稳定状态最低度 (Css-min) 的影响.
主要成果:
- 沃里康纳Css-min与年龄呈正相关性,在老年人群中观察到的水平明显更高.
- 低CYP2C19代谢者在年轻人群中表现出伏利康纳Css-min的增加,但这种影响在老年人群中并不显著.
- 在年轻患者中,CYP2C19基因型对伏利康纳水平的影响更大,而在老年人中,年龄是一个更主要的因素.
结论:
- CYP2C19基因型对伏利康纳暴露的影响显著依赖年龄.
- 低CYP2C19代谢器基因型显著增加了年轻人对沃里可纳的暴露.
- 在老年患者中,与CYP2C19基因型相比,慢性年龄成为升高沃里可纳暴露的更关键决定因素.
更多相关视频
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
08:38Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Time Course of Drug Effect
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Factors Affecting Drug Response: Overview
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
